Skip to content

Clinical trials

Phase 3 Waldenstrom Macroglobulinemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 3 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20032
20051
20061
20072
20082
20101
20133
20141
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
Alliance for Clinical Trials in Oncology2
Fred Hutchinson Cancer Center2
Gilead Sciences2
BeiGene1
Case Comprehensive Cancer Center1
European Organisation for Research and Treatment of Cancer - EORTC1
INSYS Therapeutics Inc1
Janssen Research & Development, LLC1
Jonsson Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia19
Leukemia, Lymphocytic, Chronic, B-Cell17
Lymphoma, Follicular15
Lymphoma, Large B-Cell, Diffuse15
Lymphoma, Mantle-Cell15
Hodgkin Disease14
Lymphoma, B-Cell, Marginal Zone13
Lymphoma, Non-Hodgkin13
Multiple Myeloma13
Lymphoma, Large-Cell, Immunoblastic12

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.